Projecting the impact of delayed access to elexacaftor/tezacaftor/ivacaftor for people with Cystic Fibrosis
Sanja Stanojevic, Katarina Vukovojac, Jenna Sykes, Félix Ratjen, Elizabeth Tullis, Anne L. Stephenson
Topics & Concepts
IvacaftorMedicineCystic fibrosisPopulationDiseaseIntensive care medicineInternal medicineEnvironmental healthCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesDelphi Technique in ResearchAdolescent and Pediatric Healthcare